Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations (Q73794206)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Werner J. Pichler

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Pascal Demoly

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

W Aberer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Bircher

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Blanca

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P Campi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J Fernandez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

K Brockow

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

European Network for Drug Allergy (ENDA)

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

EAACI interest group on drug hypersensitivity

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

854-863

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

Long‐term evaluation of usefulness of skin and incremental challenge tests in patients with history of adverse reaction to local anesthetics

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Understanding drug allergies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Epidemiology of drug allergy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Adverse drug reactions: mechanisms and assessment.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Oral provocation test in the diagnosis of anaphylactoid reactions to 'mild' analgesic preparations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Clinical assessment of drug-induced disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Causality assessment of adverse effects: when is re-challenge ethically acceptable?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Drug hypersensitivity: questionnaire. EAACI interest group on drug hypersensitivity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

General considerations for skin test procedures in the diagnosis of drug hypersensitivity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

A diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Acute and chronic desensitization of penicillin-allergic patients using oral penicillin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Adverse reactions to antibiotics. Clues for recognizing, understanding, and avoiding them

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Drug-induced severe skin reactions. Incidence, management and prevention

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Fixed drug eruptions in children: a series of 23 cases with provocative tests

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Fixed eruptions: causative drugs and challenge tests

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

The repeated open application test (ROAT).

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Immunologic mechanisms of penicillin allergy. A haptenic model system for the study of allergic diseases of man

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Natural evolution of skin test sensitivity in patients allergic to β-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Lack of penicillin resensitization in patients with a history of penicillin allergy after receiving repeated penicillin courses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Risk of anaphylaxis in patients receiving beta-blocker drugs

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Pathways for bradykinin formation and inflammatory disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Adverse nondrug reactions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Preventing and Managing Drug-Induced Anaphylaxis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Evaluation of systemic provocation tests in patients with suspected allergic and pseudoallergic drug reactions.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Indomethacin enhances in vitro histamine release induced by anti-IgE and Ca-ionophore but inhibits C5a-induced release reactions from basophils of atopics and normals

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Dr. Sullivan's response to Dr. Toogood's editorial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Anaphylactoid reactions and late skin reactions to iodinated contrast media: present state of the question--idea development

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

IgE-mediated allergy to granisetron and safe use of ondansetron

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Cysteinyl-leukotriene release test (CAST) in the diagnosis of immediate drug reactions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Toward the operational identification of adverse drug reactions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Conclusiveness of rechallenge in the interpretation of adverse drug reactions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Adverse drug reaction monitoring: doing it the French way

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Efficacy of intravenous pretesting and antihistamine prophylaxis in radiocontrast media-sensitive patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Routine elective penicillin allergy skin testing in children and adolescents: study of sensitization

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Cross-reactivity between penicillins and cephalosporins: clinical and immunologic studies

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Evaluation of adverse cutaneous reactions to aminopenicillins with emphasis on those manifested by maculopapular rashes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Controlled administration of penicillin to patients with a positive history but negative skin and specific serum IgE tests

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

Anaphylaxis to muscle relaxants: cross-sensitivity studied by radioimmunoassays compared to intradermal tests in 34 cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00279.X

7 January 2021

10.1034/J.1398-9995.2003.00279.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12911412%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference